This page presents investigational context in a structured format suitable for research-focused audiences
Athletes subject to anti-doping testing should not use any product labeled as BPC-157, PDA, or pentadecapeptide
A 4-week minimum hold at each dose cuts GI adverse event rates by roughly half
no aspiration required Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
Endpoints: wound closure rate (planimetry, ImageJ), granulation tissue (histological scoring), collagen organization (Picrosirius red), re-epithelialization (H&E), tensile strength (mechanical testing)
Its extended duration of action helps maintain stable B12 levels over time while providing consistent therapeutic benefit